Occurrence of Acute Leukaemia in Myeloproliferative Disorders

In a series of 306 cases of myeloproliferative disorders followed over a period of 21 years, 18 cases of well‐documented acute leukaemia were encountered. Leukaemias were either acute myeloblastic or myelomonocytic and occurred from 6 months to 20 years after the initial diagnosis. Onset was relatively abrupt and the course rapidly fatal with a median survival of 4 weeks. Due to the prolonged preleukaemic phase, it was possible to carry out a variety of clinical and laboratory observations. While no consistent features were noted, dysplastic haemopoiesis, a fall in leucocyte alkaline phosphatase activity, presence of Pelger‐Hüet anomaly and other abnormalities suggest a disturbance in granulocytic maturation. These findings suggest that, following an initial injury to a pleuripotential haemopoietic stem cell, a prolonged ‘latent’period occurs and, due to exposure to additional injurious agents or to a lack of cell regulating factors, acute leukaemia develops.

[1]  Landaw Sa Acute leukemia in polycythemia vera. , 1976, Seminars in hematology.

[2]  J. Laszlo Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. , 1975, Seminars in hematology.

[3]  N. Berlin Diagnosis and classification of the polycythemias. , 1975, Seminars in hematology.

[4]  B. McNeil,et al.  Use of indium chloride scintigraphy in patients with myelofibrosis. , 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  A. Skarin,et al.  Muramidase in myeloproliferative disorders terminating in acute leukemia , 1972, Cancer.

[6]  M. Block,et al.  The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. , 1971, Medicine.

[7]  A. J. Yates,et al.  Operating for varicose veins. , 1969, Postgraduate medicine.

[8]  J. H. Lawrence,et al.  Leukemia in polycythemia vera. Relationship to splenic myeloid metaplasia and therapeutic radiation dose. , 1969, Annals of internal medicine.

[9]  D. Rosenthal,et al.  Myeloid metaplasia: a study of 98 cases. , 1968, Postgraduate medicine.

[10]  M. N. Silverstein,et al.  Causes of death in agnogenic myeloid metaplasia. , 1969, Mayo Clinic proceedings.

[11]  W. Moloney,et al.  ESTERASE ACTIVITY IN LEUKOCYTES DEMONSTRATED BY THE USE OF NAPHTHOL AS-D CHLOROACETATE SUBSTRATE , 1960, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  L. Wasserman Polycythemia vera: its course and treatment; relation to myeloid metaplasia and leukemia. , 1954, Bulletin of the New York Academy of Medicine.

[13]  W. Dameshek Editorial: Some Speculations on the Myeloproliferative Syndromes , 1951 .